IMS HEALTH, INC.

Inactive Instrument

IMS Health, Inc. Stock

Stocks

US4499341083

Biotechnology & Medical Research

End-of-day quote NYSE
- ^USD	-

Press Releases: IMS Health, Inc.

10-02-22	IMS HEALTH USD : Standard & Poor's Announces Changes to U.S. Indices	PR
-1-11-29	Ims Health Inc. : IMS to Present at the Bear Stearns Healthcare Conference on September 11 at 7:10 a.m. and 2:30 p.m. ET	BU
-1-11-29	Ims Health Inc. : IMS to Present at the Thomas Weisel Partners Conference on September 6 at 3:15 p.m. EDT	BU
-1-11-29	Ims Health Inc. : IMS Health Names Kevin Knightly Senior VP, Business Line Management; Adel Al-Saleh Appointed President, Europe, Middle East and Africa	BU
-1-11-29	Ims Health Inc. : IMS Health Delivers 11 Percent Revenue and Operating Income Growth in Second Quarter	BU

More press releases

News in other languages: IMS Health, Inc.

16-08-25	'WiWo': GfK-Mehrheitseigner erwägen Verkauf
16-08-25	KORREKTUR/'WiWo': Mehrheitseigner des Marktforschers GfK prüft Optionen
16-08-25	'WiWo': Mehrheitseigner des Marktforschers GfK prüft Optionen
09-10-08	IMS HEALTH USD : IMS relève ses prévisions de ventes pharmaceutiques mondiales
-1-11-29	Ims Health Inc. : IMS Health prévoit une croissance de 5 à 6 pour cent du marché pharmaceutique mondial en 2007

Managers and Directors: IMS Health, Inc.

Manager	Title	Age	Since
Ari Bousbib CEO	Chief Executive Officer	64	2016-09-30
Jon Resnick PSD	President	53	2019-06-30
James Berkshire COO	Chief Operating Officer	53	2017-06-30

Director	Title	Age	Since
Ari Bousbib CHM	Chairman	64	2016-09-30

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	LONZA GROUP AG	-0.66%	+3.85%	+2.69%	+23.18%	51.61B
	REVOLUTION MEDICINES, INC.	-1.07%	+2.82%	+465.96%	+570.70%	44.89B
	IQVIA HOLDINGS INC.	+1.47%	+9.79%	+35.92%	+20.21%	42.77B
	BEONE MEDICINES AG	+1.44%	+7.77%	+19.38%	+84.65%	42.58B
	CELLTRION, INC.	-0.93%	-4.33%	+16.18%	+55.82%	31.82B
	MEDPACE HOLDINGS, INC.	+1.32%	+7.30%	+33.89%	+148.53%	17.33B
	ASCENDIS PHARMA A/S	-0.60%	+1.93%	-	-	16.63B
	EUROFINS SCIENTIFIC SE	+0.36%	+4.43%	+9.53%	+30.58%	14.76B
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.28%	+5.41%	+82.40%	+46.13%	14.09B
	Average	+0.29%	+4.43%	+83.24%	+122.48%	30.72B
	Weighted average by Cap.	+0.18%	+4.72%	+99.38%	+141.38%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

As early as today, start finding the best investment opportunities!